|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,152.30 INR | +0.36% |
|
-2.19% | -7.04% |
| 01/07 | Indian shares rise as gains in auto, financials outweigh IT losses | RE |
| 30/06 | Hindustan Unilever Limited Approves Final Dividend for the Financial Year Ended March 31, 2026 | CI |
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 10.55 | 11.31 | 11.06 | 10.62 | 10.72 | |||||
Return on Total Capital | 14.86 | 15.94 | 16.02 | 16.15 | 16.81 | |||||
Return On Equity % | 18.37 | 20.37 | 20.17 | 21.12 | 21.6 | |||||
Return on Common Equity | 18.35 | 20.37 | 20.25 | 21.17 | 21.67 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 50.53 | 47.28 | 51.55 | 51.17 | 50.58 | |||||
SG&A Margin | 14.08 | 12.98 | 15.53 | 14.83 | 14.69 | |||||
EBITDA Margin % | 23.66 | 22.59 | 22.88 | 22.63 | 22.58 | |||||
EBITA Margin % | 22.44 | 21.47 | 21.7 | 21.35 | 21.25 | |||||
EBIT Margin % | 22.41 | 21.44 | 21.67 | 21.33 | 21.23 | |||||
Income From Continuing Operations Margin % | 16.94 | 16.74 | 16.61 | 16.91 | 16.52 | |||||
Net Income Margin % | 16.93 | 16.71 | 16.6 | 16.87 | 23.33 | |||||
Net Avail. For Common Margin % | 16.92 | 16.71 | 16.6 | 16.87 | 16.49 | |||||
Normalized Net Income Margin | 14.11 | 13.69 | 13.78 | 13.68 | 13.4 | |||||
Levered Free Cash Flow Margin | 12.02 | 12.4 | 15.02 | 16.57 | 10.12 | |||||
Unlevered Free Cash Flow Margin | 12.12 | 12.49 | 15.3 | 16.92 | 10.44 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.75 | 0.84 | 0.82 | 0.8 | 0.81 | |||||
Fixed Assets Turnover | 7.31 | 7.79 | 7.22 | 6.75 | 6.9 | |||||
Receivables Turnover (Average Receivables) | 23.74 | 20.82 | 19.26 | 18.17 | 17.64 | |||||
Inventory Turnover (Average Inventory) | 6.76 | 7.65 | 7.25 | 7.31 | 6.92 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.38 | 1.41 | 1.66 | 1.33 | 1.22 | |||||
Quick Ratio | 0.89 | 0.92 | 1.2 | 0.93 | 0.7 | |||||
Operating Cash Flow to Current Liabilities | 0.8 | 0.83 | 1.2 | 0.72 | 0.71 | |||||
Days Sales Outstanding (Average Receivables) | 15.37 | 17.53 | 19 | 20.08 | 20.69 | |||||
Days Outstanding Inventory (Average Inventory) | 53.99 | 47.69 | 50.49 | 49.96 | 52.73 | |||||
Average Days Payable Outstanding | 126.72 | 109.1 | 125.59 | 128.28 | 140.21 | |||||
Cash Conversion Cycle (Average Days) | -57.36 | -43.88 | -56.1 | -58.24 | -66.79 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 2.12 | 2.41 | 2.89 | 3.32 | 3.02 | |||||
Total Debt / Total Capital | 2.08 | 2.36 | 2.8 | 3.22 | 2.93 | |||||
LT Debt/Equity | 1.51 | 1.6 | 2.15 | 2.51 | 2.25 | |||||
Long-Term Debt / Total Capital | 1.48 | 1.56 | 2.09 | 2.42 | 2.19 | |||||
Total Liabilities / Total Assets | 30.39 | 30.87 | 34.49 | 37.9 | 38.55 | |||||
EBIT / Interest Expense | 143.3 | 147.59 | 47.74 | 39.02 | 40.97 | |||||
EBITDA / Interest Expense | 156.52 | 160.45 | 52.03 | 42.94 | 45.21 | |||||
(EBITDA - Capex) / Interest Expense | 141.59 | 147.11 | 46.81 | 39.31 | 41.44 | |||||
Total Debt / EBITDA | 0.08 | 0.09 | 0.1 | 0.11 | 0.1 | |||||
Net Debt / EBITDA | -0.48 | -0.43 | -0.71 | -0.63 | -0.37 | |||||
Total Debt / (EBITDA - Capex) | 0.09 | 0.09 | 0.11 | 0.12 | 0.11 | |||||
Net Debt / (EBITDA - Capex) | -0.53 | -0.47 | -0.79 | -0.69 | -0.4 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 11.52 | 15.51 | 2.17 | 1.98 | 5.12 | |||||
Gross Profit, 1 Yr. Growth % | 7.22 | 8.07 | 11.41 | 1.22 | 3.96 | |||||
EBITDA, 1 Yr. Growth % | 10.84 | 10.32 | 3.49 | 0.89 | 2.25 | |||||
EBITA, 1 Yr. Growth % | 11.47 | 10.55 | 3.26 | 0.35 | 1.96 | |||||
EBIT, 1 Yr. Growth % | 11.5 | 10.56 | 3.29 | 0.36 | 1.97 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 11.09 | 14.14 | 1.37 | 3.78 | -0.26 | |||||
Net Income, 1 Yr. Growth % | 11.06 | 13.98 | 1.55 | 3.62 | 41.23 | |||||
Normalized Net Income, 1 Yr. Growth % | 9.86 | 12.12 | 2.85 | 1.19 | 0.25 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 10.99 | 14.04 | 1.55 | 3.61 | -0.24 | |||||
Accounts Receivable, 1 Yr. Growth % | 25.87 | 36.35 | -8.55 | 26.25 | -11.43 | |||||
Inventory, 1 Yr. Growth % | 14.45 | 3.78 | -5.39 | 9.77 | 8.47 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 9.05 | 8.01 | 12.07 | 6.38 | -5.94 | |||||
Total Assets, 1 Yr. Growth % | 2.56 | 3.64 | 7.4 | 1.76 | -0.16 | |||||
Tangible Book Value, 1 Yr. Growth % | 60.08 | 21.77 | 20.33 | -32.93 | -113.73 | |||||
Common Equity, 1 Yr. Growth % | 2.91 | 2.53 | 1.82 | -3.55 | -1.34 | |||||
Cash From Operations, 1 Yr. Growth % | -1.26 | 10.42 | 54.83 | -23.16 | -7.46 | |||||
Capital Expenditures, 1 Yr. Growth % | 65.32 | -4.16 | 25.04 | -14.58 | 0.32 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 77.89 | 19.13 | 23.8 | 12.51 | -37.47 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 76.6 | 19.03 | 25.22 | 12.7 | -36.72 | |||||
Dividend Per Share, 1 Yr. Growth % | 9.68 | 14.71 | 7.69 | 2.38 | -4.65 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 14.82 | 13.5 | 8.64 | 2.08 | 2.06 | |||||
Gross Profit, 2 Yr. CAGR % | 11.37 | 7.65 | 9.73 | 6.19 | 1.09 | |||||
EBITDA, 2 Yr. CAGR % | 12.24 | 10.56 | 6.84 | 2.18 | 1.39 | |||||
EBITA, 2 Yr. CAGR % | 15.24 | 10.99 | 6.84 | 1.79 | 0.99 | |||||
EBIT, 2 Yr. CAGR % | 15.23 | 11.01 | 6.86 | 1.81 | 1 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 14.62 | 12.61 | 7.56 | 2.57 | 1.78 | |||||
Net Income, 2 Yr. CAGR % | 14.71 | 12.51 | 7.58 | 2.58 | 20.97 | |||||
Normalized Net Income, 2 Yr. CAGR % | 13.3 | 10.99 | 7.38 | 2.02 | 0.61 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 10.01 | 12.5 | 7.62 | 2.58 | 1.71 | |||||
Accounts Receivable, 2 Yr. CAGR % | 46.38 | 31.01 | 11.67 | 7.45 | 5.75 | |||||
Inventory, 2 Yr. CAGR % | 21.67 | 8.98 | -0.91 | 1.91 | 9.12 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 16.03 | 8.53 | 10.02 | 9.19 | 0.03 | |||||
Total Assets, 2 Yr. CAGR % | 87.06 | 3.1 | 5.51 | 4.54 | 0.79 | |||||
Tangible Book Value, 2 Yr. CAGR % | -30.19 | 39.62 | 21.05 | -10.17 | -69.65 | |||||
Common Equity, 2 Yr. CAGR % | 144.17 | 2.72 | 2.17 | -0.9 | -2.45 | |||||
Cash From Operations, 2 Yr. CAGR % | 8.95 | 4.42 | 30.75 | 9.07 | -15.68 | |||||
Capital Expenditures, 2 Yr. CAGR % | 20.05 | 25.87 | 9.47 | 3.35 | -7.43 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 0.65 | 45.55 | 21.44 | 18.04 | -16.24 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 0.64 | 44.96 | 22.08 | 18.81 | -15.7 | |||||
Dividend Per Share, 2 Yr. CAGR % | 16.62 | 12.16 | 11.14 | 5 | -1.2 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 10.09 | 15.05 | 9.59 | 6.37 | 2.1 | |||||
Gross Profit, 3 Yr. CAGR % | 8.6 | 10.26 | 8.89 | 6.82 | 4.42 | |||||
EBITDA, 3 Yr. CAGR % | 11.86 | 11.59 | 8.15 | 4.82 | 2.08 | |||||
EBITA, 3 Yr. CAGR % | 12.28 | 13.64 | 8.35 | 4.63 | 1.74 | |||||
EBIT, 3 Yr. CAGR % | 12.27 | 13.64 | 8.37 | 4.65 | 1.76 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 13.61 | 14.46 | 8.72 | 6.29 | 1.65 | |||||
Net Income, 3 Yr. CAGR % | 13.62 | 14.46 | 8.73 | 6.25 | 14.12 | |||||
Normalized Net Income, 3 Yr. CAGR % | 11.01 | 12.91 | 8.2 | 5.28 | 1.35 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 10.54 | 11.34 | 8.73 | 6.26 | 1.66 | |||||
Accounts Receivable, 3 Yr. CAGR % | 10.68 | 42.96 | 16.21 | 16.33 | 0.75 | |||||
Inventory, 3 Yr. CAGR % | 16.75 | 15.39 | 3.97 | 2.53 | 4.05 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 17.62 | 13.29 | 9.69 | 8.79 | 3.89 | |||||
Total Assets, 3 Yr. CAGR % | 55.85 | 53.64 | 4.52 | 4.24 | 2.95 | |||||
Tangible Book Value, 3 Yr. CAGR % | -20.02 | -15.97 | 32.87 | -0.58 | -51.97 | |||||
Common Equity, 3 Yr. CAGR % | 84.07 | 82.85 | 2.42 | 0.23 | -1.05 | |||||
Cash From Operations, 3 Yr. CAGR % | 15.98 | 9.44 | 19.07 | 9.52 | 3.26 | |||||
Capital Expenditures, 3 Yr. CAGR % | 20.8 | 11.37 | 25.59 | 0.78 | 2.33 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 11.03 | 6.46 | 37.9 | 18.4 | -4.57 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 11.31 | 6.42 | 38.05 | 18.88 | -3.8 | |||||
Dividend Per Share, 3 Yr. CAGR % | 15.62 | 15.98 | 10.65 | 8.14 | 1.68 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 9.6 | 11.25 | 9.5 | 9.67 | 6.51 | |||||
Gross Profit, 5 Yr. CAGR % | 9.65 | 8.91 | 9.05 | 8.61 | 5.7 | |||||
EBITDA, 5 Yr. CAGR % | 14.41 | 12.82 | 9.82 | 7.72 | 5.39 | |||||
EBITA, 5 Yr. CAGR % | 14.78 | 13.27 | 10.06 | 8.75 | 5.34 | |||||
EBIT, 5 Yr. CAGR % | 14.77 | 13.25 | 10.07 | 8.75 | 5.36 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 14.57 | 14.19 | 11.15 | 9.55 | 5.89 | |||||
Net Income, 5 Yr. CAGR % | 14.68 | 14.18 | 11.16 | 9.55 | 13.47 | |||||
Normalized Net Income, 5 Yr. CAGR % | 14.09 | 13.03 | 9.54 | 8.42 | 5.1 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 12.75 | 12.34 | 9.36 | 7.75 | 5.86 | |||||
Accounts Receivable, 5 Yr. CAGR % | 17.81 | 20.71 | 11.07 | 27.53 | 11.91 | |||||
Inventory, 5 Yr. CAGR % | 10.02 | 11.09 | 9.34 | 9.8 | 6 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 12.26 | 12.22 | 14.52 | 11.63 | 5.72 | |||||
Total Assets, 5 Yr. CAGR % | 35.03 | 32.55 | 33.33 | 31.71 | 3.01 | |||||
Tangible Book Value, 5 Yr. CAGR % | -9.8 | -7.71 | -5.6 | -13.69 | -26.4 | |||||
Common Equity, 5 Yr. CAGR % | 48.72 | 47.19 | 45.45 | 43.11 | 0.44 | |||||
Cash From Operations, 5 Yr. CAGR % | 11.78 | 10.52 | 21.68 | 9.29 | 3.72 | |||||
Capital Expenditures, 5 Yr. CAGR % | 1.94 | 5.74 | 16.13 | 8.09 | 11.17 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 13.18 | 9.64 | 15.07 | 10.94 | 12.98 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 13.3 | 9.79 | 15.49 | 11.21 | 13.34 | |||||
Dividend Per Share, 5 Yr. CAGR % | 14.87 | 14.29 | 13.81 | 11.46 | 5.75 |
- Stock Market
- Stocks
- HINDUNILVR Stock
- Financials Hindustan Unilever Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















